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Abstract:  OBJECTIVES: To determine the optimal clinical reading time for the 
transcutaneous measurement of oxygen saturation (SpO2) and transcutaneous CO2 
(TcPCO2) in awake spontaneously breathing individuals, considering the overshoot 
phenomenon (transient overestimation of arterial PaCO2).  EXPERIMENTAL SECTION: 
Observational study of 91 (75 men) individuals undergoing forced spirometry, 
measurement of SpO2 and TcPCO2 with the SenTec monitor every two minutes until 
minute 20 and arterial blood gas (ABG) analysis. Overshoot severity: (a) mild (0.1–1.9 mm 
Hg); (b) moderate (2–4.9 mm Hg); (c) severe: (>5 mm Hg). The mean difference was 
calculated for SpO2 and TcPCO2 and arterial values of PaCO2 and SpO2. The intraclass 
correlation coefficient (ICC) between monitor readings and blood values was calculated as 
a measure of agreement. RESULTS: The mean age was 63.1 ± 11.8 years. Spirometric values: 
FVC: 75.4 ± 6.2%; FEV1: 72.9 ± 23.9%; FEV1/FVC: 70 ± 15.5%. ABG: PaO2: 82.6 ± 13.2; 
PaCO2: 39.9.1 ± 4.8 mmHg; SaO2: 95.3 ± 4.4%. Overshoot analysis: overshoot was mild in 33 
(36.3%) patients, moderate in 20 (22%) and severe in nine (10%); no overshoot was observed 
in 29 (31%) patients. The lowest mean differences between arterial blood gas and TcPCO2 
was –0.57 mmHg at minute 10, although the highest ICC was obtained at minutes 12 and 
14 (>0.8). The overshoot lost its influence after minute 12. For SpO2, measurements were 
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reliable at minute 2. CONCLUSIONS: The optimal clinical reading measurement 
recommended for the ear lobe TcPCO2 measurement ranges between minute 12 and 14. 
The SpO2 measurement can be performed at minute 2.  
Keywords: transcutaneous CO2; optimal reading time; overshoot phenomenon 
 
Abbreviations: 
SpO2: oxygen saturation  
TcPCO2: transcutaneous partial pressure of carbon dioxide  
PaCO2: arterial pressure of carbon dioxide  
PaO2: arterial oxygen pressure 
ABG: arterial blood gas analysis 
SpO2: transcutaneous arterial oxygen saturation 
FEV1: forced spirometry value in the first second 
FVC: forced vital capacity 
PFTs: pulmonary function testings 
1. Introduction 
During the last 50 years, there has been a growing interest in arterial blood gas measurements for 
calculating PaO2 [1,2] and PaCO2 [3,4]. Non-invasive measurement of both PaCO2 and PaO2 has 
presented major technical and practical problems [2], but pulse oximetry, introduced in 1985, proved 
to be effective for the non-invasive assessment of oxygenation during sleep [1] and exercise [2]. No 
techniques were available for non-invasive continuous monitoring of PaCO2.  
At the turn of the century, Rohling and Biro [5] and Tschupp and Fanconi [6] published the first 
descriptions of a monitor that combined the elements of an optical pulse oximetry sensor with a 
Severinghaus-type PaCO2 sensor, which has been used in several clinical situations [7]. One of the key 
points that remain to be determined is the time at which the monitor offers the most reliable 
measurement.  
In a previous study, we validated the combined oximetry and transcutaneous CO2 (TcPCO2) ear-
lobe monitor (Sentec Corporation, Inc) designed for SpO2 and TcPCO2 measurements [3]. In that study 
we established empirically that the monitor needed a maximum stabilization time of 17 minutes in 
order to perform the reading of the PaCO2 value. Considering that SpO2 reading is much faster than 
PaCO2, the purpose of this study was to determine the optimal time for the TcPCO2 reading of the 
Sentec monitor in a cohort of clinically stable individuals including patients and normal controls. 
2. Experimental Section 
Based on our previous results, we hypothesized that the stabilization time at which the Sentec 
monitor was reliable for SpO2 and PaCO2 measurements would be <17 minutes [3]. Sensors 2010, 10                                       
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Patients 
 
Inclusion criteria: (a) a consecutive Caucasian adult population referred to the respiratory function 
testing clinic of our hospital for forced spirometry and arterial blood gas analysis. 
Exclusion criteria: (a) active smoking habit; b) jaundice; (c) recent hospital admission (<3 months); 
d) clinical hypotension; (e) refusal to participate. Since our previous validation study had shown that 
the over- and underestimation by the monitor was not clinically relevant [3], patients were not 
stratified and grouped according to pulmonary function, even though this variable was measured. 
 
Methods 
 
The study was observational and cross-sectional. All patients underwent forced spirometry (System 
1070, Series 2E/1085, MedGraphics, St. Paul, MI, USA) on the day of the study. Spirometry was 
carried out in accordance with the guidelines of the Spanish Society for Pulmonology and Thoracic 
Surgery (SEPAR) [8]. Reference values used were those published for a Mediterranean population [9]. 
SpO2 and TcPCO2 were then measured with the V-SignTM combined monitor (SenTec Inc, Therwil, 
Switzerland). A screen reading of the Sentec monitor for SpO2 and TcCO2 was performed every two 
minutes until minute 20. We defined the overshoot phenomenon as the transient overestimation of 
arterial PaCO2 by the monitor at least during two consecutive readings (2 minutes). The severity of 
overshoot was classified as follows: (a) mild: transient overestimation of arterial PaCO2 between 0.1 
and 1.9 mm Hg; (b) moderate: transient overestimation of arterial PaCO2 between 2 and 4.9 mm Hg; c) 
severe: transient overestimation of arterial PaCO2 > 5 mm Hg. 
After the stabilization period and once screen monitor readings were completed, arterial blood gas 
(ABG) analysis was performed in accordance with SEPAR guidelines [10] which include the use of 
subcutaneous anaesthesia before puncture. The sample for arterial blood gas analysis was processed in 
two analyzers and hemoximeters belonging to the respiratory function testing laboratory (Radiometer 
ABL 500 series, Copenhagen, Denmark; Radiometer OSM3 hemoximeter) and immediately 
afterwards using the instruments at our intensive care unit (ICU) (Radiometer ABL 700 series; 
Radiometer OSM3 hemoximeter). Although the two laboratories are on the same floor and close to one 
another, the blood samples were transported between the two sites on ice. At least two readings were 
taken with each analyzer for each blood sample. The optimal value was always taken (highest PaO2 
and lowest PaCO2) when the values differed by less than 1 mm Hg; otherwise a third reading was 
recorded. The arithmetic mean of the readings from the two analyzers was calculated and the result 
was taken as the reference value from the arterial blood gas analysis. The body temperature of the 
patient was specified on analysis of the blood sample. 
 
Statistical Analysis 
 
Anthropometric, spirometric and ABG data were expressed as means (SD). ABG values processed 
in the respiratory function testing unit were compared with the ICU values by calculating the mean 
differences for PaCO2 and oxygen saturation (SpO2). The Pearson correlation coefficients (r) between 
PaCO2 and TcPCO2 and between SaO2 and SpO2 were determined. Finally, a concordance study was Sensors 2010, 10                                       
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performed by calculating the single measure intraclass correlation coefficient (ICC). An ICC > 0.71 
indicates a good concordance between the two measures, and a very good concordance when it is >0.9. 
The ANOVA test was used to compare TcPCO2 at different measurement times. The study was 
approved by the ethics committee of our hospital. 
3. Results 
Ninety-one patients (75 men) were included in the study. Demographic data, pulmonary function 
testing (PFTs) and ABG values are shown in Table 1.  
Table 1. Demographic data and pulmonary function testing and arterial blood gas values 
(mean ± SD) of 91 patients included in the study.  
Variable  Mean ± SD  Range 
Age (years)  63.1 ± 11.8   37–86 
FEV1 (l)  2.21 ± 0.87  0.51–4.33 
FEV1%  72.92 ± 23.9  17–124 
FVC (l)  3.13 ± 0.92  1.23–5.14 
FVC %  75.4 ± 16.2  37–107 
FEV1/FVC  70 ± 15.6  24–88 
pH  7.41 ± 0.02  7.35–7.48 
PaCO2 (mm Hg)  39.91 ± 4.85  29–55 
PaO2 (mm Hg)  82.6 ± 13.23  49.2–126 
HCO3 (mmol/L)  25.5 ± 2.14  19–32 
SaO2 (%)  95.7 ± 2.30  85–99 
Hb (g/L)  14.26 ± 1.79  9.2–19 
 
The heterogeneity of the cohort of patients reflects the presence of normal controls as well as COPD 
patients with different degrees of airway obstruction. 
Table 2. Values of TcPCO2 readings, mean differences between PaCO2 and TcPCO2, 
correlation and intraclass correlation coefficient for individual measures each 2 minutes.  
  2’  4’  6’  8’  10’  12’  14’  16’  18’  20’ 
Mean TcPCO2 
(SD) 
30.1  
(7.5) 
36.04  
(6.7) 
38  
(7.5) 
39.2  
(6.2) 
39.3  
(5.8) 
39  
(5.6) 
38.7  
(5.5) 
38.6  
(5.3) 
38.2  
(5.3) 
38.15  
(5.1) 
Mean PaCO2-TcPCO2 
 (SD) 
9.6  
(7.6) 
3.8 
(5.8) 
1.8 
(6) 
0.7 
(4.2) 
0.57 
(3.5) 
0.87 
(3.3) 
1.14 
(3) 
1.28 
(2.9 
1.6 
(3) 
1.7 
(2.8) 
95 % CI  8.0-11.2  2.5-5  0.5-3  -0.2-1.5  -0.17-1.32  0.17-1.56  0.5-1.8  0.6-1.9  0.9-2.2  1.1-2.3 
Pearson correlation 
coefficients (r) 
0.292  0.549  0.594  0.741  0.791  0.810  0.834  0.834  0.822  0.838 
ICC  0.267  0.519  0.54  0.718  0.777  0.801  0.827  0.830  0.819  0.836 
The upper row shows the time in minutes. TcPCO2: Transcutaneous CO2. SD: standard deviation. 
CI: confidence interval. ICC: intraclass correlation coefficient for individual measures Sensors 2010, 10                                       
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As Table 2 shows, the mean differences between arterial and transcutaneous CO2 in the first two 
readings were substantial (4 min). Mean differences were below 1 mm Hg after minute 6, but the 
maximum agreement with an ICC > 0.8 was achieved after minute 12 of measurement. These 
agreement values did not worsen in the following minutes. Regarding oximetry saturation values, the 
agreement between oximeter amd arterial oxygen saturation was very good even in the first reading 
(minute 2: Table 3).  
Table 3. Values of SpO2 readings, mean differences between SaO2 and SpO2, correlation 
and intraclass correlation coefficient for individual measures each 2 minutes.  
  2’  4’  6’  8’  10’  12’  14’  16’  18’  20’ 
Mean SpO2 
(SD) 
96.8 
(2.1) 
96.4 
(2.2) 
96.38 
(2.1) 
96.33 
(2.18) 
96.24 
(2.3) 
96.3 
(2.3) 
96.3 
(2.1) 
96.2 
(2.4) 
96.3 
(2.1) 
96.4 
(2.1) 
Mean SaO2-SpO2 
(SD) 
-1.14 
(1.32) 
-0.71 
(1.5) 
-0.7 
(1.49) 
-0.68 
(1.6) 
-0.59 
(1.69) 
-0.61 
(1.72) 
-0.68 
(1.46) 
-0.52 
(2) 
-0.61  
(1.45) 
-0.78 
(1.48) 
95 % CI  -0.86; 
-1.42 
-0.4; 
-1.02 
-0.38; 
-1.01 
-0.34; 
-1.01 
-0.23; 
-0.94 
-0.24; 
-0.97 
-0.37; 
-0.99 
-0.09; 
-0.94 
-0.3; 
-0.9 
-0.46; 
-1.09 
Pearson 
correlation 
coefficients (r) 
0.822  0.782  0.772  0.738  0.721  0.710  0.780  0.634  0.788  0.776 
ICC  0.818  0.780  0.768  0.735  0.721  0.709  0.775  0.633  0.785  0.772 
The upper row shows the time in minutes. SpO2: pulsoximeter oxygen saturation. SD: standard 
deviation. CI: confidence interval. ICC: intraclass correlation coefficient for individual measures 
 
Overshoot analysis: overshoot was mild in 33 (36.3%) patients, moderate in 20 (22%) and severe in 
9 (10%); no overshoot was observed in 29 (31%) patients. No association was found between 
demographics or baseline levels of PaCO2 and overshoot. As Table 4 shows, early readings (first  
10 minutes) showed statistical significant differences in patients with moderate-to severe overshoot 
and those without. These differences disappear after minute 12, at which point ICC was >0.8 (Table 2). 
Figure 1 shows the relationship between the different groups at each time measurement. 
Table 4. Mean baseline PaCO2 and transcutaneous CO2 readings every 2 minutes (in   
mm Hg) in patients with and without several degrees of overshoot.  
Overshoot 
PaCO2 
(mmHg) 
2’  4’  6’  8’  10’  12’  14’  16’  18’  20’ 
None (n = 29) 
40.2 ± 4.9  26.3 ± 8.7  32.7 ± 8.2  35.2 ± 7.1  36.2 ± 6.4  36.9 ± 5.7  37.1 ± 5.5  37.3 ± 5.6  38 ± 5.6  37.6 ± 5.5  38 ± 5 
Light  
(n = 33) 
39.5 ± 4.3  30.9 ± 6.3  36.3 ± 5  38.4 ± 4.8  39.1 ± 4.9  39.2 ± 4.8  39 ± 4.7  38.7 ± 4.7  38.5 ± 4.7  38.6 ± 4.7  38.2 ± 4.6 
Moderate  
(n = 20) 
39.9 ± 6.1  31.5 ± 5.3  38.0 ± 5.6
b  40.7 ± 6.3
 b  41.6 ± 6.6
 b  41.7 ± 6.9
b  41 ± 7  40.0 ± 6  39.5 ± 6.5  39 ± 6.4  39 ± 6.2 
Severe (n = 9)  40.2 ± 3.6  36.3 ± 6.5
a  41.3 ± 4.8
b  43.3 ± 4.6
 b  43.5 ± 5
 b  42.9 ± 4.2
 b  40.7 ± 3.7  39.5 ± 3.4  38.4 ± 3.5  38.4 ± 3.9  39.5 ± 4.1 
The upper row shows the values of arterial PCO2 and the time in minutes. a) p < 0.05 between severe overshoot 
and no overshoot (ANOVA test, Bonferroni post hoc analysis).  b) p < 0.05 between no overshoot vs. moderate 
and severe overshoot.  Sensors 2010, 10                                       
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Figure 1. The TcPCO2 values tend to converge after minute 10. At minutes 12 and 14, the 
overshoot phenomenon seems to disappear. 
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When patients with severe overshoot are excluded from the analysis, readings before minute 14 
improved slightly, with ICC values of 0.240 (m2), 0.521 (m4) 0.655 (m6), 0.736 (m8), 0.782 (m10), 
0.804 (m12) and 0.838 (m14). After minute 14 no relevant differences were observed.  
4. Discussion and Conclusions 
The stabilization time had been established empirically in a previous study [3] on the basis of the 
opinion of the nurse who considered the correct reading to be at about 14 ± 3 minutes. The next step 
was to establish the optimal (shortest and reliable) screen monitor reading time for the TcPCO2 and for 
the SpO2. We decided to use an interval of two minutes between measurements since previous 
experience had shown that this was the time taken by the monitor to detect the occurrence of an  
event [11]. As in our previous study [3] we took readings until 20 minutes after attaching the sensor to 
the ear lobe. None of our patients had dark skin, were smokers or had jaundice, and so the possible 
effects of these factors on the results of pulse oximetry could be ruled out. Arterial blood gas analysis 
was performed in accordance with SEPAR guidelines [10]. To avoid systematic calibration errors of 
the analyzers, we processed our samples in two different analyzers and took the mean of the values 
obtained as the reference arterial blood gas value, as in our previous study [3].  
As Table 2 shows, the mean differences between arterial and transcutaneous CO2 are substantial in 
the first two readings (4 min). By minute 6 the mean differences fell below 1 mm Hg, but the 
maximum agreement with a ICC > 0.8 was achieved after measurement at minute 12; the fact that 
these agreement values did not worsen in the following readings suggest that there was no drift during 
these first 20 minutes of monitoring. Regarding oximetry saturation values, the agreement between 
oximeter and arterial oxygen saturation was excellent from minute 2 onwards.  
Two opposite phenomena may interfere with TcPCO2 readings during the first minutes of 
monitoring. First, the arterialization of capillary blood due to vasodilatation lasts several minutes. 
Second, the metabolism of the cells on the skin surface is increased by the application of heat, which 
increases the release of CO2 from the cells, thus causing a transient overestimation of true PaCO2 (the Sensors 2010, 10                                       
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“overshoot phenomenon”). It is believed that the overshoot usually precedes the complete 
vasodilatation of subdermal tissue. Kagawa et al. [12] confirmed the overshoot phenomenon during 
the early stages of TcPCO2 measurement. Hirabashi et al. [13] examined a method for avoiding 
overshoot in eight adult patients under general anaesthesia, and found that their device prevented it if 
the probe was heated to 45 ºC rather than to 42º. Since overshoot is temperature-dependent, it might be 
thought that heating patients’ tissue to a lower temperature would reduce the phenomenon, but 
Hirabashi et al. observed the opposite: by heating the tissue to a higher temperature in the early stages, 
overshoot and vasodilatation tended to coincide in time, thus minimizing the problem. We should 
stress that Hirabashi’s patients were under general anaesthesia, whereas our patients were awake and 
breathing spontaneously. 
The device we tested heats the tissue to 41 ºC. Under these conditions, we observed severe 
overshoot (>5 mm Hg) in 10% of patients. Interestingly, mean TcPCO2 between patients with or 
without overshoot (Table 4) was not statistically different after minute 12, suggesting that this 
phenomenon interferes with readings only in the first 12 minutes. Moreover, when patients with severe 
overshoot were excluded from the analysis, the intraclass correlation coefficient after minute 12 did 
not change. Overshoot seems to be an individual phenomenon that is unpredictable before monitoring. 
High early TcPCO2 readings may alert the clinician to its presence (Table 4) although the 
interpretation of this value depends on the patient’s baseline PaCO2. We were unable to identify a cut-
off point that was sufficiently sensitive and specific for use in clinical practice.   
Measurements are a fundamental part of both clinical practice and investigation. Repeated 
measurements of the same variable in the same subject do not usually yield the same value. This may 
be due to natural variations in the subject, variations in the measurement process, or both [14]. 
Therefore, statistical methods to calculate the error are important. As previously discussed [3], 
although the Pearson correlation coefficient is useful as a first approach, it measures the strength of 
linear association of two variables and indicates how the values of one vary as a function of the other; 
so it only allows us to rule out the negative hypothesis, that is, that there is no linear association 
between the two measurements (the reference measurement and the measurement for validation). A 
strong correlation, however, does not necessarily mean that the two measurements agree [15-16]. To 
validate a technique, we must not only show that the two variables vary in the same direction but that 
they do so in the same way. 
The reliability of a device or method of analysis should thus be evaluated with tests of agreement. 
We used the ICC in our study because a number of authors have suggested that it provides a measure 
of agreement for continuous variables. This coefficient is not subject to the problems inherent in the 
linear correlation coefficient: it does not depend on the range of values of the sample, and the result is 
unaffected by the order in which the readings are presented or by inter-subject variability, although 
changes in measurement scales do have an effect [3]. It is also an excellent indicator of reliability of 
the measurement [3].  
Besides the mathematical results, in clinical practice we have to take the decision which is most 
clinically useful, and which does not always coincide with the most exact measurement. Kagawa and 
Severinghaus underlined [17] that the best moment to take a TcPCO2 measurement was at minute 30 
after placing the ear probe, but in many clinical situations, the prompt availability of the result is at 
least as important as the value itself – for instance, in the emergency room or in ambulatory care when Sensors 2010, 10                                       
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visits tend to be scheduled very frequently. In these cases, shortening the time required to obtain the 
measurement is crucial. We observed that, at minutes 8 and 10, the mean differences between arterial 
and transcutaneous CO2 values were clinically insignificant and that the intraclass correlation 
coefficient was very good, showing that in most measurements at this time the correlation between the 
two techniques would be reliable. Taking into consideration the overshoot phenomenon, what happens 
in these early readings is that some values compensate the others and make the mean differences for 
the whole group very low. Beyond minute 12, although the mean differences are not lower, the ICC is 
higher, thus illustrating the compensation of the overshoot phenomenon by vasodilatation. Figure 1 
shows that at minute 12 readings tend to converge, thus minimizing the error. 
Although direct measurement of PaCO2 remains the gold standard, it provides only a single 
measurement of what is often a rapidly changing and evolving clinical picture. As a result, the clinical 
need remains for a means to continuously monitor PaCO2 without the need for repeated blood gas 
analysis. Transcutaneous CO2 monitoring can be applied in situations [18,19] that generally preclude 
end tidal CO2 monitoring such as high frequency ventilation, apnea testing, and noninvasive 
ventilation [20]. Moreover, the technique has shown to be more reliable than capnometry [4,21]. 
This study has several limitations. First, we had only one value for the PaCO2 and we assumed that 
it did not change throughout the study. The second limitation is that our patients were awake and 
spontaneously breathing, which makes it difficult to compare our results with other studies with 
anaesthetized patients. Finally, our monitor is different from others frequently used in other papers. 
Therefore, our conclusions apply to the monitor and circumstances described and may not be 
applicable to all situations. 
In our setting, ambulatory care of COPD patients [22] in specialized units [23] is very frequent. 
Repeated arterial punctures for the measurement of ABG have remained one of the most important 
patient concerns. A solution for oxygenation measurement was found many years ago with arterial 
pulse-oximetry, but the approach to PaCO2 with non-invasive methods has remained a problem until 
recently. Since a single measurement is needed for every outpatient, it is crucial to establish the 
optimal time at which to perform the reading. Transcutaneous carbon dioxide monitoring may be a 
useful adjunct in various clinical scenarios and may help to improve control and therapy in many 
patients in the coming years [24].  
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